Golden Heart Flower

Developing disease-modifying medicines for rare glycogen and lysosomal storage diseases.

Health Tech & Life Sciences
Active
Pre-Funding Afula, Israel Founded 2020
Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
7
HQ
Afula, Israel
Sector
Health Tech & Life Sciences
Website ↗LinkedIn ↗Registrar ID: 516280682 (GHF-GOLDEN HEART FLOWER LTD)

About

Golden Heart Flower (GHF) is an Israel-based pharmaceutical company focused on developing therapies for Adult Polyglucosan Body Disease (APBD) and other rare glycogen storage and lysosomal storage diseases. The company's lead compound, GHF-201, is a small molecule therapy capable of degrading polyglucosan bodies. GHF was founded by a family with a member diagnosed with APBD, driven by a personal mission to find treatments for uncurable disorders. The company has received Orphan Drug Designation from the U.S. FDA for GHF-201 for the treatment of glycogen storage disease type IV, including APBD. GHF is also expanding its activities to include development of solutions for lysosomal storage diseases and other diseases with a higher prevalence in the overall population.

Headcount over time

7 employees (2026-09) · 1 point
7 7 2026-09

Offices

Afula, Israel · HQ / main office

Q&A

What is Golden Heart Flower's primary focus?
Golden Heart Flower is an early-stage pharmaceutical company focused on developing disease-modifying medicines for rare diseases, specifically Glycogen Storage Diseases (GSDs) and Lysosomal Storage Diseases (LSDs).
When was Golden Heart Flower founded?
Golden Heart Flower was founded in May 2018.
Where is Golden Heart Flower headquartered?
Golden Heart Flower is headquartered in Afula, North District, Israel.
What is the current employee count for Golden Heart Flower?
Golden Heart Flower has 1-10 employees.
What is Golden Heart Flower's current funding stage?
Golden Heart Flower is currently in the Pre-Funding stage.
What sector does Golden Heart Flower operate in?
Golden Heart Flower operates in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drugs Discovery & Development.
What is the product stage of Golden Heart Flower?
Golden Heart Flower's product is currently in the R&D stage.

Team · 10

Adi Moreh
Founder · Co-Founder
Shlomo Schneider
Founder · Co-Founder, Chairman of the Board
Yaniv Glazer
CEO
Yossi Gilgun-Sherki
Head of Product Development
David Perlmutter
Board Member
Itzik Schneider
Board Member
Shira Orel-Ifrah
Finance & Accounting
Doron Shinar
Pre-clinical and toxicology
Danny Fishelovitch
CMC
Uri Sprecher
Project Manager

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyPharmaceuticals

Tags

pharmaceuticalsbiopharmaceuticalpharma-companiesrare-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteghf-pharma.com
LinkedInlinkedin.com/company/81364322

Identifiers & details

Legal nameGHF-GOLDEN HEART FLOWER LTD
Founded2020
Employees (exact)7

Radar intelligence

Web history (Wayback)

Domainghf-pharma.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516280682
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-11-15
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events1 — annual_report (1)
Registered addressהעמל 2 עפולה

Recent registry events

DateEvent
2026-05-05דו~ח שנתי